Breast Biopsy Devices Market To Reach $4094.80 Million By 2033

August 2016 | Report Format: Electronic (PDF)

Breast Biopsy Devices Market Growth & Trends

The global breast biopsy device market is expected to reach USD 4094.80 million by 2033, according to a new report by Grand View Research, Inc. The Breast biopsy device market is projected to grow at a productive rate in the next few years. The key factors supporting the industry’s growth involve the rising awareness levels with regard to diagnostic procedures through cancer screening programs, global rise in breast cancers in women, and the high demand for less-invasive procedures. However, the degree of risk is directly proportional to the extent of procedure invasiveness. Biopsy causes pain and is a stressful procedure for patients, moreover, approximately 60% to 80% of breast biopsies in women result in a benign judgment. Therefore, women are encouraged to consult experts for a second opinion before undergoing a biopsy procedure, which is likely to hinder the growth of the market.

The test type segment is categorized into needle breast biopsies and open surgical biopsies. The former is further segmented into fine-needle aspiration, core-needle, and vacuum-assisted core biopsy. The fine-needle aspiration segment is estimated to hold the largest share for the year 2015 whereas the vacuum-assisted core biopsy segment is anticipated to witness a lucrative growth during the study period. The open surgical biopsy industry is sub-segmented into Incisional biopsy and Excisional biopsy.

On the basis of products, the industry is categorized into needles, tables, localization wires, and guidance systems. Additionally, the guidance systems segment of the industry is further categorized on the basis of imaging systems, such as ultrasound, mammography, and magnetic resonance imaging.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/breast-biopsy-device-market

Breast Biopsy Devices Market Report Highlights

The Asia Pacific region is anticipated to witness the highest growth rate during the forecast period. The high frequencies of breast cancer prevailing in women as well as the increase in awareness of cancer screening programs are the factors fueling the market growth.
North America accounts for the largest market share, followed by the European market. The heightened awareness about breast cancer that advocate regular checkups and screening programs along with the demand for accurate and minimally caustic procedures are factors that are responsible for the rapid market growth.
The mammography-guided stereotactic segment is estimated to hold the largest market share followed by the magnetic resonance imaging-guided category. The rise in demand for rapid and precise diagnostic imaging tools in determining the exact location of the tumor or lump in the breast area is one of the major factors driving the growth of this industry
The core needle biopsy (CNB) segment dominated the market in 2025, driven by its widespread clinical acceptance as the standard diagnostic technique for suspicious breast lesions.

Breast Biopsy Devices Market Report Segmentation

Grand View Research has segmented the global breast biopsy devices market on the basis of test type, guidance, product, and region:

Breast Biopsy Devices Product Outlook (Revenue, USD Million, 2021 - 2033)

Biopsy Guidance Systems
Biopsy Drivers & Handpieces
- Vacuum-Assisted Biopsy (VAB) Drivers
- Core Needle Biopsy (CNB) Guns
  - Automated
  - Semi-Automated
Biopsy Tables
- Prone Tables
- Upright/Add-on Tables
Biopsy Consumables
- Needles & Probes
- Site Markers & Clips
By Shape/Design
Standard Geometric Markers
- Ring
- Cross
- Ribbon
- Others
Advanced Anchoring Markers
- Anchor
- Wing, "U" Shape
- Q" Shape
3D / Expandable Markers
- 3D Ribbon
- 3D Sphere
- 3D Mesh
Localization Systems
- Traditional Wires
- Wireless Seeds-RFID/Magnetic
Other Consumables